Provider review
No BS RX review: four pharmacies named with their addresses, and no company name anywhere
Ask most GLP-1 sellers who makes your medication and you'll get a category: "licensed compounding pharmacies". No BS RX gives you four names, four street addresses and four phone numbers, and says on every single plan that the drug is made to order under a prescription. That's the most complete answer to that question we've published. Its weight-loss pages also make no claim about results at all — no percentage, no timeline, nothing to check. And it never says which company is taking your money.
Names all four pharmacies with their addresses and states the compounding tier on every plan, and names no company at all.
Worth trusting if
- You want to know exactly which pharmacy might fill your prescription, and to look it up yourself
- You want the compounding tier stated rather than left for you to infer
- You want a seller that sells on price and process rather than on a weight-loss percentage
Be skeptical if
- You want to know which company you are contracting with, which its terms never say
- You want a certificate of analysis rather than a promise that one exists
- You want the low-dose program backed by evidence, because no trial studied a reduced dose
Compounded only
Phase 3 trials
Named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens nobsrx.com. A link is not a recommendation to take anything.
Provenance
What No BS RX actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $179 a month, and that is the ongoing rate rather than a first month.
- Compounded tirzepatide injection — $249 a month, ongoing.
- Compounded oral semaglutide — low-dose and standard programs — $199 a month standard, or $140 for the low-dose injectable programs.
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
3
Molecules with human evidence
For the use they are sold for, out of 3 products reviewed here. The evidence belongs to the molecule, not to No BS RX.
3
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from No BS RX’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“Standard injectable semaglutide — most popular. No dose-based price changes. Licensed provider review. 503A pharmacy fulfillment. Our partner pharmacies use pharmaceutical-grade APIs — not research-grade — sourced from FDA-registered manufacturers.”
Read on the No BS RX site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, mean weight reduction of about 15% on semaglutide 2.4 mg. Listed as the molecule's evidence base; No BS RX cites no trial anywhere on its site.
There is no outcome claim on this page to weigh against the trial, and that is the finding. No BS RX sells its semaglutide on price, on who fills the prescription and on the fact that a provider has to say yes — never on how much weight you will lose. Its one substantive non-price claim is about sourcing, and it is unusually specific: pharmaceutical-grade active ingredients rather than research-grade, from FDA-registered manufacturers, each with a certificate of analysis. That is a meaningful distinction and it is asserted rather than shown. No certificate, lot number or test result is published anywhere on the site, so the claim is present and unproven rather than false.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“Standard injectable tirzepatide program. No dose-based price changes. Licensed provider review. 503A pharmacy fulfillment.”
Read on the No BS RX site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly, mean reduction of roughly 20% at the top dose. Again the molecule's evidence base, not a citation this seller makes.
Same as the semaglutide row: a description of the plan, the pharmacy tier and the review requirement, and no promise about a result. Nothing here reaches past SURMOUNT-1 because nothing here reaches at all. The trial tested the manufacturer's approved tirzepatide rather than a compounded preparation, which is true of every product on this page and of nearly every seller we review.2
Compounded oral semaglutide — low-dose and standard programsSemaglutide · Compounded (503A)Claim matches the trials
“Standard oral semaglutide program. Low-dose oral semaglutide program. No dose-based price changes. 503A pharmacy fulfillment.”
Read on the No BS RX site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. Tested semaglutide as a once-weekly injection at 2.4 mg, titrated up to that maintenance dose. It is not a trial of a daily compounded tablet and not a trial of a deliberately reduced dose.
No BS RX sells a low-dose program as its own product at its own price rather than as a cheap first rung, and claims nothing for it. That restraint matters more here than on the standard programs, because low-dose GLP-1 treatment is not what any of the trials studied — participants in STEP 1 were titrated up to a maintenance dose and measured there. A seller quoting trial percentages beside a deliberately lower dose would be overstating; this one quotes no percentages at all. The oral route has the same gap: no trial cited on this site tested a compounded daily tablet.1
Dispensing chain
Who actually fills your prescription
- Red Rock Compounding Pharmacy
- Health Warehouse
- Precision Medicine
- Triad Rx
Read the full account
No BS RX names every pharmacy that might fill your prescription, with a street address and a telephone number for each: Red Rock Compounding Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. Every plan also states that the medication is made to order under a prescription rather than dispensed ready-made. That is the most complete answer to the who-makes-it question in either of our registries. Two caveats. You do not get to choose — the terms say No BS RX does not control which pharmacy fills a given prescription. And some of these pharmacies are named by other sellers we review, which tells you they are shared suppliers and nothing about who owns whom. No clinician is named at any level.
Read on the No BS RX site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No BS RX makes the most specific sourcing claim in this batch and publishes nothing to back it. Its pricing commitments say the partner pharmacies use pharmaceutical-grade active ingredients rather than research-grade, sourced from FDA-registered manufacturers, that every one comes with a certificate of analysis, and that there is no gray-market sourcing. That is a real and meaningful distinction — research-grade material is not made to be given to people. But no certificate, lot number, batch or test result appears anywhere on the site, so what exists is an assertion that certificates exist. Its separate sleep program carries two unsourced prevalence statistics about sleep apnea, which concern a different condition and are outside what this page grades.
Read on the No BS RX site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
No BS RX publishes no list of states and claims no nationwide coverage. Its pricing page says only that prices depend on provider review and state availability, which admits coverage varies without saying how. Checked across the homepage, the pricing page, the FAQ and the terms on September 13, 2026.
Read the full licensing claim
Its terms name four pharmacies and their addresses and no operating company at all — no business name, no registered address, no state of incorporation and no choice-of-law clause naming one. No clinician is named; every plan says only that a licensed provider reviews it.
Read on the No BS RX site, September 2026.
Regulatory
The FDA warning letter
Checked, and none found
Assessment
What holds up, and what does not
- It names all four pharmacies that might fill your prescription, with street addresses and phone numbers.
- Every plan states that the medication is made to order under a prescription rather than dispensed ready-made.
- Its weight-loss pages carry no percentage, no timeline and no before-and-after, so nothing overstates the trials.
Show 4 more
- It sells the low-dose program as its own product rather than quoting trial figures beside a reduced dose.
- Its sourcing claim is specific — pharmaceutical-grade ingredients rather than research-grade, from registered manufacturers.
- It says plainly that prices depend on provider review and what your state allows.
- No FDA warning letter, for the brand or for any of the four named pharmacies.
- No company is named anywhere — the terms give four pharmacy addresses and no business, state or governing law.
- No certificate of analysis is published, so the sourcing claim is an assertion rather than a document.
- No trial is cited anywhere, so nothing connects its products to published evidence.
Show 4 more
- No clinician is named — only "licensed provider review" on each plan.
- You cannot choose your pharmacy; the terms say No BS RX does not control which one fills a prescription.
- Its sleep program carries two prevalence statistics with no source attached.
- Its sleep medication support names no molecule, so what is being prescribed is unclear.
Verdict
The bottom line
On the one question most sellers dodge — who actually makes this — No BS RX gives the fullest answer we have published, and it gives it before you hand over anything. Then it declines to say who it is. Ask for the certificate of analysis it says exists, and ask which company you would be contracting with. Everything else here is unusually straight.
Opens nobsrx.com. A link is not a recommendation to take anything.
Four names, four addresses
Ask most sellers in this market who makes your medication and you get a category. No BS RX gives you this, in its terms:
Red Rock Compounding Pharmacy — 1240 East 100 South, Suite 220, St. George, UT 84790 · 435-703-2900
Health Warehouse — 7107 Industrial Rd., Florence, KY 41042 · 800-748-7001
Precision Medicine — 2657 Merrick Road, Bellmore, NY 11710 · 516-833-6262
Triad Rx — 26258 Pollard Road, Daphne, AL 36526 · 251-380-7630
Every plan also says 503A pharmacy fulfillment — a pharmacy that makes the drug to order for one named patient. Across both our sites, the usual finding is that neither 503A nor 503B appears on a seller's website at all.
You can't pick which one. The terms say No BS RX doesn't control it. You can look all four up before you order, which is the part that matters.
Full analysis — 3 more sectionsIt claims nothing about results · The claim that is specific, and unproven · Where the low-dose program sits
It claims nothing about results
We swept the homepage, the pricing page and every program row on 13 September 2026 for a weight-loss percentage, a pounds figure, a timeline, a satisfaction rate or a before-and-after.
There aren't any.
What's there instead are commitments about commerce — no fake intro rate, no markup layered through referral networks, provider review required. So there's nothing on this site for STEP 1 1 or SURMOUNT-1 2 to contradict.
That's the absence of an overstatement. It isn't evidence. No BS RX cites no trial anywhere either.
The claim that is specific, and unproven
One exception, and it's an interesting one:
"Our partner pharmacies use pharmaceutical-grade APIs — not research-grade — sourced from FDA-registered manufacturers. Every API comes with a Certificate of Analysis. No gray-market sourcing."
That distinction is real. Research-grade material isn't made to be given to people, and it turns up in this market more often than anyone would like.
But no certificate is published. No lot number, no batch, no result. What exists on the site is a statement that certificates exist. Ask for one.
Where the low-dose program sits
No BS RX sells low-dose semaglutide and tirzepatide as products in their own right, at their own prices.
Worth knowing what that means for evidence: no trial studied it. STEP 1 titrated participants up to 2.4 mg and measured them there. A deliberately lower dose is a different treatment, and nothing published tells you what it does.
The right way to sell that is without quoting trial percentages next to it — which is exactly what No BS RX does, by quoting no percentages at all.
Questions
Frequently asked questions
Which pharmacy fills a No BS RX prescription?
One of four, and it names all of them with addresses and phone numbers: Red Rock Compounding in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. Every plan also says the medication is made to order under a prescription, and while you don't get to choose which of the four, you can look them all up first.
Does it say how much weight I'd lose?
No — not a percentage, a pounds figure or a timeline anywhere on the site. That means nothing here overstates what the trials found, which is the opposite of the usual problem. It also means the site gives you nothing to set expectations against.
What's a certificate of analysis, and can I see one?
It's a lab document stating what's actually in a batch of ingredient — identity, purity, potency. No BS RX says every active ingredient comes with one and publishes none of them, so what's on the site is a promise that they exist. Ask for one before you order.
Is a low-dose program as good?
Nothing published tells you. Both major trials titrated people up to a full maintenance dose and measured results there, so a deliberately reduced dose sits outside what's been studied. No BS RX doesn't quote trial figures next to it, which is the right call.
Who is No BS RX?
The site doesn't say. Its terms name four pharmacies, their addresses and their phone numbers, and no operating company — no business name, no address, no state. It's a strange omission on a site this open about everything else.
Glossary
Key terms
Show definitions
- 503A
- A pharmacy that makes a drug to order for one named patient with a prescription. What it produces is not an FDA-approved product, and the FDA has not evaluated its safety, effectiveness or quality.
- Active pharmaceutical ingredient
- The drug substance itself, before it's made into an injection or a tablet. Pharmaceutical-grade is intended for medicines; research-grade is not made to be given to people.
- Certificate of analysis
- A lab document stating what a specific batch of ingredient actually contains — identity, purity and potency. It is evidence about one batch, not about a company.
Compare
Others selling what No BS RX sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off No BS RX's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 2 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, titrated to a 2.4 mg maintenance dose. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.